11/24/2025
Proud to be part of this tremendously important work with the goal of preventing cancer of the stomach and pancreas.
Imagine fighting a disease that hides itself—an "invisible cloak" making it incredibly hard to find—until it's too late. That's often the reality for patients diagnosed with pancreatic and stomach cancers.
For these awful diseases, diagnosis commonly occurs in the advanced stages, when treatment options may be limited and outcomes are poor. By the time most patients know they have it, the chance for recovery has virtually vanished.
To fight this heartbreaking reality, our community stepped up. The Foundation for Barnes-Jewish Hospital recently raised $2 million to launch PREVENT, a new program at Siteman Cancer Center, based at Barnes-Jewish Hospital and WashU Medicine. This powerful collaboration is dedicated to solving the problem of late-stage diagnosis for these cancers.
This investment brings together a super team of researchers and physicians, pooling multimillion-dollar resources and leading-edge technology. PREVENT is more than research—it has the power to give patients back their options by:
🧠 Attracting the Best: Funding fellowships to bring the brightest minds to our research teams, allowing gastric and pancreatic researchers to collaborate, working side-by-side.
🔬 Finding Cancer Earlier: Developing brand new diagnostic tools to finally pierce the "invisible cloak" and catch pancreatic and stomach cancer at the earliest, most curable stage.
📈 Expanding Resources: Like the Tissue and BioBank, which allows researchers to better understand these cancers and test new precision treatments.
This partnership is fundamental to speeding up life-saving discoveries through research, which in turn advances patient care. “With our world-class team of experts, we are uniquely positioned to identify and propel the most promising ideas, ensuring that they swiftly translate into real-world benefits for patients,” says Matthew Ciorba, MD, director of the Inflammatory Bowel Disease Center and cancer researcher at WashU Medicine and Barnes-Jewish Hospital. “We’re grateful for this support that has the power to catalyze progress and save lives.”
Learn more about the life-changing impact of this $2 million investment: https://heyor.ca/E2hV5k